V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20212400 | 20079034 | 1.56 | 63.9 | Palliative (P) | 2018-03-28 | 2018-04-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101592347 |
| 20212401 | 20079035 | 1.66 | 81 | null | 2016-11-27 | 2016-12-10 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100495119 |
| 20212402 | 20079036 | null | 82 | null | 2019-07-11 | 2019-08-05 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101772809 |
| 20212403 | 20079037 | 1.68 | 72.45 | null | 2019-04-16 | 2019-04-17 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 100648658 |
| 20212404 | 20079038 | 1.69 | 52.3 | Palliative (P) | 2018-05-30 | 2018-06-05 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100671028 |
| 20212405 | 20079039 | 1.66 | 95 | Palliative (P) | 2016-03-23 | 2016-04-20 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101695783 |
| 20212406 | 20079040 | 1.8 | 84.3 | Adjuvant (A) | 2019-11-12 | 2019-11-12 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100103610 |
| 20212407 | 20079041 | 1.83 | 83.4 | Palliative (P) | 2017-11-09 | 2017-11-29 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100718415 |
| 20212409 | 20079042 | 1.84 | 94.8 | 02 | 2017-09-05 | 2017-10-03 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100383837 |
| 20212410 | 20079043 | 1.62 | 83.3 | null | 2019-02-14 | 2019-03-01 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101825116 |
| 20212411 | 20079044 | 1.84 | 61.7 | Palliative (P) | 2017-05-05 | 2017-05-05 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100445381 |
| 20212412 | 20079045 | null | null | Neo-adjuvant (N) | 2019-01-15 | 2019-01-19 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100514884 |
| 20212413 | 20079046 | 0 | 79.75 | Neo-adjuvant (N) | 2016-07-05 | 2016-07-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100616920 |
| 20212414 | 20079047 | 0 | 0 | Palliative (P) | 2018-10-25 | 2018-11-26 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100479589 |
| 20212415 | 20079048 | 1.7 | 40.2 | Neo-adjuvant (N) | 2017-11-14 | 2017-11-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100484392 |
| 20212416 | 20079049 | 1.55 | 83.5 | null | 2016-04-22 | 2016-05-06 | Cisplatin +Fluorouracil (2 wk) | null | null | CISPLATIN + FLUOROURACIL | 101804402 |
| 20212419 | 20079050 | 1.62 | 85 | Curative (C) | 2019-01-16 | 2019-01-27 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100328269 |
| 20212420 | 20079051 | 0 | 0 | Palliative (P) | 2018-06-21 | 2018-07-18 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100936002 |
| 20212421 | 20079052 | 1.6 | null | Palliative (P) | 2016-06-27 | 2016-07-01 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 101243648 |
| 20212422 | 20079053 | 1.81 | 96 | Palliative (P) | 2017-11-07 | 2017-11-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101796717 |
| 20212423 | 20079054 | 1.64 | 60 | Palliative (P) | 2018-05-19 | 2018-05-19 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100135797 |
| 20212424 | 20079055 | 1.64 | 94.9 | Neo-adjuvant (N) | 2017-08-30 | 2017-09-04 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101715988 |
| 20212425 | 20079056 | 1.73 | 66.25 | Palliative (P) | 2019-07-27 | 2019-07-27 | CISPLATIN + FLUOROURACIL | null | N | CISPLATIN + FLUOROURACIL | 101778197 |
| 20212426 | 20079057 | 1.74 | 76.1 | Neo-adjuvant (N) | 2019-02-26 | 2019-02-26 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100173247 |
| 20212427 | 20079058 | 1.65 | 63.8 | null | 2018-01-15 | 2018-01-20 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101165088 |
| 20212428 | 20079059 | 1.72 | 70 | Palliative (P) | 2018-01-30 | 2018-02-08 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101443647 |
| 20212429 | 20079060 | 1.7 | 91 | Palliative (P) | 2019-06-12 | 2019-09-09 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101837702 |
| 20212431 | 20079061 | 1.63 | 72 | Neo-adjuvant (N) | 2018-04-24 | 2018-05-09 | CAPECITABINE + CARBOPLATIN | N | Y | CAPECITABINE + CARBOPLATIN | 101858865 |
| 20212432 | 20079062 | 1.73 | 69.9 | Palliative (P) | 2019-04-03 | 2019-04-20 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101582638 |
| 20212433 | 20079063 | 0 | 0 | Curative (C) | 2012-08-19 | 2018-08-09 | Capecitabine (21days) + Carboplatin | 02 | N | DOXORUBICIN EMBOLISATION | 100576849 |
| 20212434 | 20079064 | 1.68 | 71 | Palliative (P) | 2016-09-18 | 2016-09-28 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101057729 |
| 20212435 | 20079065 | 1.8 | 71.8 | Curative (C) | 2018-05-05 | 2018-05-13 | Capecitabine (21days) + Carboplatin | N | null | TRIAL UNSPECIFIED | 101684398 |
| 20212436 | 20079066 | 1.68 | 62.2 | Palliative (P) | 2016-12-24 | 2017-01-01 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 101203375 |
| 20212437 | 20079067 | 1.64 | 100.9 | Curative (C) | 2018-06-12 | 2018-06-19 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101534084 |
| 20212438 | 20079068 | 1.55 | 74.55 | 03 | 2016-10-17 | 2016-10-25 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101183208 |
| 20212439 | 20079069 | 1.67 | 56 | Neo-adjuvant (N) | 2016-04-30 | 2016-05-13 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 100007646 |
| 20212440 | 20079070 | 1.69 | 77.6 | Curative (C) | 2019-04-01 | 2019-04-17 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100605056 |
| 20212441 | 20079071 | 1.6 | 84.7 | Curative (C) | 2018-08-13 | 2018-08-13 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100539263 |
| 20212442 | 20079072 | 1.7 | 60 | Palliative (P) | 2019-06-14 | 2019-07-02 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 101643300 |
| 20212443 | 20079073 | 1.7 | 49.4 | Palliative (P) | 2020-03-17 | 2020-03-18 | Cisplatin +Fluorouracil (3 wk) | N | N | CISPLATIN + FLUOROURACIL | 100415575 |
| 20212444 | 20079074 | 1.65 | 51.35 | Neo-adjuvant (N) | 2016-11-13 | 2016-11-16 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100919051 |
| 20212445 | 20079075 | 1.57 | 70.6 | Palliative (P) | 2018-09-10 | 2018-09-24 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100549517 |
| 20212446 | 20079076 | 1.48 | 74 | Palliative (P) | 2016-06-28 | 2016-06-28 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101208903 |
| 20212447 | 20079077 | 1.78 | 73.8 | Palliative (P) | null | 2017-01-22 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100124259 |
| 20212448 | 20079078 | 1.74 | 91.6 | Palliative (P) | 2017-08-28 | 2017-09-14 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101317081 |
| 20212449 | 20079079 | 1.57 | 78.6 | Palliative (P) | 2021-04-09 | 2021-04-17 | Capecitabine (21days) + Carboplatin | N | N | CISPLATIN + FLUOROURACIL | 101558204 |
| 20212450 | 20079080 | 1.58 | 62.8 | Palliative (P) | 2018-04-27 | 2018-04-29 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100873112 |
| 20212451 | 20079081 | 1.64 | 71.55 | Curative (C) | 2017-09-26 | 2017-10-10 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100528108 |
| 20212452 | 20079082 | 1.68 | 80 | Adjuvant (A) | 2018-06-22 | 2018-07-05 | CAPECITABINE + CARBOPLATIN | 02 | y | CISPLATIN + FLUOROURACIL | 100102989 |
| 20212453 | 20079083 | 1.77 | 64.5 | 03 | 2019-03-25 | 2019-04-11 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100151182 |